Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary aldosteronism: management issues.

William F Young1

  • 1Division of Endocrinology and Metabolism, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA. Young.William@Mayo.edu

Annals of the New York Academy of Sciences
|October 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood.

European journal of endocrinology·2026
Same author

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

EBioMedicine·2026
Same author

Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.

The Journal of clinical endocrinology and metabolism·2025
Same author

Duration of adrenal insufficiency after surgical treatment of endogenous hypercortisolism: a prospective cohort study.

European journal of endocrinology·2025
Same author

A comparison of bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling at Mayo Clinic for the subtype evaluation of corticotropin-dependent cushing syndrome.

Pituitary·2025
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Primary aldosteronism, once rare, is now a common cause of hypertension. Early screening and diagnosis lead to better hypertension management and targeted treatments for patients.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Primary aldosteronism (PA) was historically considered rare but is now recognized as a frequent cause of secondary hypertension.
  • Improved screening techniques have revealed the prevalence of PA, necessitating updated diagnostic and management strategies.
  • Timely diagnosis of PA can lead to hypertension cure or significant improvement with targeted pharmacotherapy.

Purpose of the Study:

  • To review the current understanding of primary aldosteronism, emphasizing its increased prevalence.
  • To outline screening, diagnostic, and subtype evaluation methods for primary aldosteronism.
  • To discuss therapeutic approaches based on the identified subtypes of primary aldosteronism.

Main Methods:

  • Screening involves assessing the plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio and PAC levels.

Related Experiment Videos

  • Confirmation of PA requires demonstrating inappropriate aldosterone secretion via saline suppression testing or 24-hour urinary aldosterone measurement.
  • Subtype evaluation utilizes imaging techniques like computerized tomography (CT) and adrenal venous sampling.

    • Main Results:

    • Elevated PAC/PRA ratio and PAC levels suggest PA, but confirmation is essential.
    • Primary aldosteronism presents as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperplasia (IHA).
    • CT scans aid in identifying unilateral macroadenomas, guiding surgical decisions, but may yield ambiguous results.

    Conclusions:

    • Screening for PA is recommended in patients with hypertension and hypokalemia, and treatment-resistant hypertension.
    • Unilateral adrenalectomy is a primary treatment for APA, while IHA is managed medically.
    • Adrenal venous sampling is crucial for resolving diagnostic ambiguities and guiding treatment in complex cases.